NDAORALCAPSULEPriority Review
Approved
Jun 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
HIV Protease Inhibitors
Pharmacologic Class:
Protease Inhibitor
Indications (1)
Clinical Trials (5)
Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Started Feb 2010
18 enrolled
Infection, Human Immunodeficiency VirusHIV Infections
A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
Started Sep 2009
42 enrolled
HIV Infections
Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers
Started Apr 2008
32 enrolled
Healthy
Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients
Started Oct 2007
85 enrolled
HIV Infections
Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects
Started Aug 2007
52 enrolled
Healthy